Analyst Ratings for Mirum Pharmaceuticals (MIRM)
MIRM Rating Summary
MIRM Price Target Summary
- Highest: $195.00 (H.C. Wainwright)
- Lowest: $118.00 (Leerink)
- Average: $150.14
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$150.14 (+87.4%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$150.14 (+87.4%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/2/2026 | Citi » Updated 10/12/2026 |
Yigal Nochomovitz | New Coverage | Buy (N/A) |
184.00 (160.00) |
96.33 (80.14) |
-16.81% | Details |
| 5/20/2026 | JPMorgan » Updated 7/2/2026 |
Jessica Fye | New Coverage | Overweight (N/A) |
125.00 (115.00) |
95.49 (80.14) |
-16.07% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
